Journal of Rheumatic Diseases

Table. 1.

Baseline characteristics

Patient characteristics All patients (n=47)
Age (yr) 53.8±8.8
Sex, female 44 (93.6)
Fibromyalgia duration (mo) 83.7±58.2
Widespread Pain Index (range: 0∼19) 10.5±5.0
Symptom Severity Score (range: 0∼12) 7.2±2.2
VAS of pain* (range: 0∼100) 68.2±18.7
Fibromyalgia Impact Questionnaire (range: 0∼100) 62.8±18.0
Insomnia Severity Index (range: 0∼28) 15.4±6.6
SF-36
Physical functioning 40.2±20.6
Role limitation due to physical condition 26.0±34.6
Bodily pain 36.2±18.1
General health 32.3±13.8
Vitality (energy and fatigue) 26.9±14.5
Social functioning 46.8±22.0
Role limitation due to emotional condition 39.0±45.7
Mental health 40.7±17.7
Health change 30.3±27.6
Associated symptoms
Tinnitus 22 (46.8)
Headache 41 (87.2)
Irritable bowel syndrome 6 (12.7)
Used medication 34 (72.3)

Values are presented as mean±standard deviation or number (%). SF-36: Short-form Health Survey. *The Visual Analog Scale (VAS) of pain intensity is a 100-point linear gauge in which 0=no pain and 100=worst pain imaginable. Satisfies the Rome IV diagnostic criteria. Medication including selective serotonin reuptake inhibitor/serotonin-norepinephrine reuptake inhibitor/Pregabalin.

J Rheum Dis 2021;28:31~37 https://doi.org/10.4078/jrd.2021.28.1.31
© J Rheum Dis